Circle Pharma
About:
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Website: http://circlepharma.com
Top Investors: Pfizer, Eli Lilly, Mission BioCapital, The Column Group, Eli Lilly & Company Foundation
Description:
Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
$208M
$1M to $10M
San Francisco, California, United States
2012-01-01
info(AT)circlepharma.com
Matthew Jacobson, Scott Lokey
11-50
2024-09-03
Private
© 2025 bioDAO.ai